A breakthrough technology that converts hard-to-process iron ore into high-grade concentrate has been deployed at the world's largest, marking a major milestone in China's effort to reduce its reliance on imported iron ore.
Researchers have developed a dual-functional cell engager that combines cell bridging and targeted chemotherapeutic delivery to improve chimeric antigen receptor T (CAR T) cell therapy for relapsed and refractory leukemias.
CONTACT US
86-10-82544817
62551257
ghb@ipe.ac.cn
Institute of Process Engineering,Chinese Academy of Sciences,1 North 2nd Street, Zhongguancun, Haidian District, Beijing 100190, PR China